Enterprise Value
$1.44 B
-$132.69 M-8.42%
Fri, 07 Feb 2025 22:50:50 GMT
Summary
- As of February 8, 2025, CLDX enterprise value is $1.44 billion, with a fall of -$132.69 million (-8.42%) during the most recent trading day.
- Over the past year, CLDX enterprise value has dropped by -$532.21 million (-26.95%).
- CLDX enterprise value is now -55.65% below its all-time high of $3.25 billion.
Performance
CLDX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
CLDX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -8.4% | -8.3% | -8.3% |
| 1 m1 month | -19.7% | -19.4% | -19.4% |
| 3 m3 months | -16.3% | -15.9% | -15.9% |
| 6 m6 months | -32.1% | -31.9% | -31.9% |
| ytdytd | -12.1% | -11.9% | -11.9% |
| 1 y1 year | -26.9% | -26.5% | -38.1% |
| 5 y5 years | +4461.6% | +3665.2% | +863.2% |
CLDX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.7% | $1.44 B | at low | |
| 3 m | 3-month | $1.87 B | -22.8% | $1.44 B | at low |
| 6 m | 6-month | $2.92 B | -50.5% | $1.44 B | at low |
| 1 y | 1-year | $3.25 B | -55.6% | $1.44 B | at low |
| 3 y | 3-year | $3.25 B | -55.6% | $936 M | +54.2% |
| 5 y | 5-year | $3.25 B | -55.6% | $9.61 M | >+9999.0% |
| alltime | all time | $3.25 B | -55.6% | $1.67 M | >+9999.0% |
Celldex Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $1.44 B(-12.1%) |
| 2024 | $1.64 B(-24.8%) |
| 2023 | $2.18 B(+5.1%) |
| 2022 | $2.08 B(+17.4%) |
| 2021 | $1.77 B(+170.8%) |
| 2020 | $653.50 M(+2058.7%) |
| 2019 | $30.27 M(+161.8%) |
| 2018 | $11.56 M(-96.7%) |
| 2017 | $353.11 M(-8.1%) |
| 2016 | $384.17 M(-74.0%) |
| 2015 | $1.48 B(-8.2%) |
| 2014 | $1.61 B(-19.3%) |
| 2013 | $1.99 B(+376.0%) |
| 2012 | $418.30 M(+253.9%) |
| 2011 | $118.19 M(-2.8%) |
| 2010 | $121.60 M(+33.7%) |
| 2009 | $90.96 M(+12.3%) |
| 2008 | $81.02 M(+151.7%) |
| Date | Value |
|---|---|
| 2007 | $32.19 M(-49.0%) |
| 2006 | $63.13 M(-46.5%) |
| 2005 | $118.09 M(+0.6%) |
| 2004 | $117.43 M(-25.2%) |
| 2003 | $157.05 M(+264.3%) |
| 2002 | $43.11 M(-78.4%) |
| 2001 | $199.71 M(-41.8%) |
| 2000 | $343.00 M(+224.3%) |
| 1999 | $105.77 M(+57.6%) |
| 1998 | $67.10 M(+12.3%) |
| 1997 | $59.74 M(+202.5%) |
| 1996 | $19.75 M(-60.5%) |
| 1995 | $49.94 M(+40.6%) |
| 1994 | $35.52 M(-65.9%) |
| 1993 | $104.17 M(+30.2%) |
| 1992 | $80.03 M(-34.0%) |
| 1991 | $121.33 M(+483.7%) |
| 1990 | $20.79 M |
FAQ
- What is Celldex Therapeutics enterprise value?
- What is the all time high enterprise value for Celldex Therapeutics?
- What is CLDX enterprise value year-to-date change?
- What is Celldex Therapeutics enterprise value year-on-year change?
What is Celldex Therapeutics enterprise value?
The current enterprise value of CLDX is $1.44 B
What is the all time high enterprise value for Celldex Therapeutics?
Celldex Therapeutics all-time high enterprise value is $3.25 B
What is CLDX enterprise value year-to-date change?
Celldex Therapeutics enterprise value has changed by -$199.03 M (-12.12%) since the beginning of the year
What is Celldex Therapeutics enterprise value year-on-year change?
Over the past year, CLDX enterprise value has changed by -$532.21 M (-26.95%)